Computed Tomography–Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer

PURPOSE: Effective preoperative regimens and biomarkers for pancreatic ductal adenocarcinoma (PDAC) are lacking. We prospectively evaluated fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX)-based treatment and imaging-based biomarkers for borderline resectable PDAC. METHODS: Eligibl...

Descripción completa

Detalles Bibliográficos
Autores principales: Koay, Eugene J., Katz, Matthew H.G., Wang, Huamin, Wang, Xuemei, Prakash, Laura, Javle, Milind, Shroff, Rachna, Fogelman, David, Avila, Santiago, Zaid, Mohamed, Elganainy, Dalia, Lee, Yeonju, Crane, Christopher H., Krishnan, Sunil, Das, Prajnan, Fleming, Jason B., Lee, Jeffrey E., Tamm, Eric P., Bhosale, Priya, Lee, Jeffrey H., Weston, Brian, Maitra, Anirban, Wolff, Robert A., Varadhachary, Gauri R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446521/
https://www.ncbi.nlm.nih.gov/pubmed/32914036
http://dx.doi.org/10.1200/PO.19.00001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446521/
https://www.ncbi.nlm.nih.gov/pubmed/32914036
http://dx.doi.org/10.1200/PO.19.00001

Ejemplares similares